Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant

• Marisa Simon,

  Affiliation Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Texas, United States of America

  ⨯
• Fahmi Mesmar,

  Affiliation Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Texas, United States of America

  ⨯
• Luisa Helguero,

  Affiliation Institute for Research in Biomedicine, Department of Biosciences, University of Aveiro, Aveiro, Portugal

  ⨯
• Cecilia Williams

  * E-mail: cecilia.williams@scilifelab.se

  Affiliations Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Texas, United States of America, Division of Proteomics, SciLifeLab, School of Biotechnology, KTH – Royal Institute of Technology, Solna, Sweden, Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden

  ⨯